Malaysia to use AstraZeneca vaccine

Malaysia to use AstraZeneca vaccine

Bibliographic Details
Main Author:	Povera, Adib
Format:	Newspaper
Language:	English
Published:	2021
Online Access:	http://psasir.upm.edu.my/id/eprint/84884/1/Malaysia%20to%20use%20astrazeneca%20vaccine.jpg

Similar Items

Thromboembolism and the Oxford-AstraZeneca vaccine
by: Perera, R, et al.
Published: (2021)

AstraZeneca Vaccine: Should we be concerned
by: Zainab Arif, et al.
Published: (2022-05-01)

Busting the Breast Cancer with AstraZeneca’s Gefitinib
by: S. Chemmalar, et al.
Published: (2023-01-01)

Lipschütz ulcers after AstraZeneca COVID-19 vaccination
by: Maria Bracho-Borro, et al.
Published: (2023-08-01)

Comparison of the Antibody Responses Following Vaccination with AstraZeneca and Sinopharm
by: Enayat Anvari, et al.
Published: (2022-09-01)

The first report of myocarditis followed by AstraZeneca vaccination in Iran
by: Karo Servatyari, et al.
Published: (2022-06-01)

Acute rejection following COVID-19 vaccine (AstraZeneca)
by: Prem P Varma, et al.
Published: (2022-01-01)

Reactogenicity and Immunogenicity of the Pfizer and AstraZeneca COVID-19 Vaccines
by: Waleed H. Mahallawi, et al.
Published: (2021-12-01)

Membranoproliferative Glomerulonephritis following the Oxford AstraZeneca COVID-19 Vaccine
by: Kawtar Hassani, et al.
Published: (2021-01-01)

Amyotrophic neuralgia secondary to Vaxzevri (AstraZeneca) COVID-19 vaccine
by: J.A. Crespo Burillo, et al.
Published: (2021-09-01)

A case of Thrombotic Thrombocytopenic Purpura following the AstraZeneca Vaccine
by: Effat Iranijam, et al.
Published: (2022-12-01)

Immunogenicity of Oxford-AstraZeneca COVID-19 vaccine in Vietnamese healthcare workers
by: Van Vinh Chau, N, et al.
Published: (2021)

Capillary Leakage Syndrome Following the Administration of AstraZeneca Vaccine; Case report
by: Sepideh Safanavaiee, et al.
Published: (2024-01-01)

[Translated article] Lipschütz Ulcers After the AstraZeneca COVID-19 Vaccine
by: N. González-Romero, et al.
Published: (2022-12-01)

New-onset bullous pemphigoid triggered by AstraZeneca COVID-19 vaccine
by: Yin-Cheng Chao, et al.
Published: (2022-01-01)

Systemic lupus erythematosus with acrocyanosis after AstraZeneca COVID‐19 vaccination
by: Huei‐Jing Wang, et al.
Published: (2022-12-01)

Phenotypic appearance of central retinal vein occlusion post AstraZeneca vaccine
by: Peter Cackett, et al.
Published: (2022-04-01)

Immunogenicity of Oxford-AstraZeneca COVID-19 vaccine in Vietnamese health-care workers
by: Chau, NVV, et al.
Published: (2022)

Acute Inflammatory Pericarditis following First Dose of COVID-19 Vaccine (AstraZeneca)
by: Mohammed Alshaikh, et al.
Published: (2022-01-01)

Letter to the Editor in Response to the "Comparison of the Antibody Responses Following Vaccination with AstraZeneca and Sinopharm"
by: Rujittika Mungmunpuntipantip, et al.
Published: (2022-12-01)

A case of pityriasis rubra pilaris following AstraZeneca COVID-19 vaccine
by: Miki Wada, BMedSc, MD, et al.
Published: (2022-06-01)

Acquired Thrombotic Thrombocytopenic Purpura after AstraZeneca Vaccine: a Case Report
by: Fatemeh Yaghoobi, et al.
Published: (2022-01-01)

Outcomes of AstraZeneca vaccine for relapse and Covid-19 infection in people with multiple sclerosis
by: Nazanin Razazian, et al.
Published: (2022-09-01)

Zoster infection after vaccination with the AstraZeneca COVID-19 vaccine: A case report
by: Laurent Dupoirieux
Published: (2022-01-01)

Turun padang daftar vaksin AstraZeneca untuk warga emas
by: Utusan Borneo Sabah
Published: (2021)

New Tendencies in the Development of the EU Competition Law – the AstraZeneca case
by: K. V. Entin
Published: (2011-10-01)

Cross-Reactivity between Half Doses of Pfizer and AstraZeneca Vaccines—A Preliminary Study
by: Krzysztof Lukaszuk, et al.
Published: (2022-03-01)

Thrombocytopenia and Intracranial Venous Sinus Thrombosis after “COVID-19 Vaccine AstraZeneca” Exposure
by: Marc E. Wolf, et al.
Published: (2021-04-01)

Acquired thrombotic thrombocytopenic purpura with possible association with AstraZeneca‐Oxford COVID‐19 vaccine
by: Mona Al‐Ahmad, et al.
Published: (2021-08-01)

Cutaneous lupus erythematosus flare with vitiligo-like depigmentation following the AstraZeneca COVID vaccine
by: Farrah Bakr, MBBS, MRCP, et al.
Published: (2022-12-01)

Adverse effects of Oxford-AstraZeneca COVID-19 vaccine among Egyptian healthcare workers
by: Mai Al Kaffas, et al.
Published: (2022-10-01)

Paroxysmal supra-ventricular ventricular tachycardia after AstraZeneca COVID-19 vaccine injection
by: Y.-T. Lin, et al.
Published: (2022-01-01)

Myocarditis following AstraZeneca (an adenovirus vector vaccine) COVID‐19 vaccination: A case report
by: Shakiba Hassanzadeh, et al.
Published: (2022-04-01)

Rhabdomyolysis following Oxford/AstraZeneca COVID-19 vaccination; two case reports from Iran
by: Marzieh Hashemi, et al.
Published: (2024-01-01)

Impact of Improper Storage of ChAdOx1-S (AstraZeneca) Vaccine on Its Efficacy and Safety
by: Marek Mikołajczyk, et al.
Published: (2022-12-01)

Analysis of Thrombotic Adverse Reactions of COVID-19 AstraZeneca Vaccine Reported to EudraVigilance Database
by: Mansour Tobaiqy, et al.
Published: (2021-04-01)

Herpes‐like skin lesion after AstraZeneca vaccination for COVID‐19: A case report
by: Mohammadreza Ardalan, et al.
Published: (2021-10-01)

Neuralgia amiotrófica secundaria a vacuna contra COVID-19 Vaxzevria (AstraZeneca)
by: J.A. Crespo Burillo, et al.
Published: (2021-09-01)

Active surveillance of adverse events following the first dose of COVID-19 vaccination – Oxford–AstraZeneca (Covishield) vaccine
by: Sangeetha Merrin Varghese, et al.
Published: (2022-01-01)

Infographics on risks associated with COVID-19 and the willingness to get the AstraZeneca vaccine: two randomized online experiments
by: Lisa Felgendreff, et al.
Published: (2024-02-01)